Cargando…
Restoring immune tolerance in neuromyelitis optica: Part II
Neuromyelitis optica spectrum disorder (NMO/SD) and its clinical variants have at their core the loss of immune tolerance to aquaporin-4 and perhaps other autoantigens. The characteristic phenotype is disruption of astrocyte function and demyelination of spinal cord, optic nerves, and particular bra...
Autores principales: | Bar-Or, Amit, Steinman, Larry, Behne, Jacinta M., Benitez-Ribas, Daniel, Chin, Peter S., Clare-Salzler, Michael, Healey, Donald, Kim, James I., Kranz, David M., Lutterotti, Andreas, Martin, Roland, Schippling, Sven, Villoslada, Pablo, Wei, Cheng-Hong, Weiner, Howard L., Zamvil, Scott S., Smith, Terry J., Yeaman, Michael R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015540/ https://www.ncbi.nlm.nih.gov/pubmed/27648464 http://dx.doi.org/10.1212/NXI.0000000000000277 |
Ejemplares similares
-
Restoring immune tolerance in neuromyelitis optica: Part I
por: Steinman, Larry, et al.
Publicado: (2016) -
B lymphocytes in neuromyelitis optica
por: Bennett, Jeffrey L., et al.
Publicado: (2015) -
Challenges and opportunities in designing clinical trials for neuromyelitis optica
por: Weinshenker, Brian G., et al.
Publicado: (2015) -
Update on biomarkers in neuromyelitis optica
por: Melamed, Esther, et al.
Publicado: (2015) -
Neuromyelitis optica spectrum disorder: Patient experience and quality of life
por: Beekman, Janine, et al.
Publicado: (2019)